TET2 and hematopoietic and lymphoid system neoplasm: Unsurprisingly, the current study’s two most frequently mutated genes were TET2 and DNMT3A. Those mutations are widely described in hematologic neoplasms with inconsistent conclusions regarding their pathogenicity (14–17).